{"frequencyBands":{"HP:0040280":[100,100],"HP:0040281":[80,99],"HP:0040282":[30,79],"HP:0040283":[5,29],"HP:0040284":[1,4],"HP:0040285":[0,0]},"page":{"anchorSlug":"post-transplant-lymphoproliferative-disease","columns":[{"gene":"","key":"population-8bfd114fb2c60b663618","label":"Post-transplant lymphoproliferative disease","mondoId":"MONDO:0019088","onsetQualifier":null,"originColumnKey":"MONDO:0019088/ORPHA:70568","originalViews":[{"key":"MONDO:0019088/ORPHA:70568","label":"Post-transplant lymphoproliferative disease","scopeLabel":"ORPHA:70568","sourceScope":"This column retains the native source entry. It is not a pooled estimate for the umbrella condition."}],"recordKeys":["05b01c7e8b6468d99cdc25db697dd314200a9f3261cf885e9177e7db96993f92","1a5f64013ef0d2d7f94fc0a415cdcc9298a793a82d0ad1310456c45e0cb26d16","3d11a7187248142e69da02e6e75c495afffe5b20ad15bea2ca60388bdff4fcc8","3dd0c855a1d53c48079c4b67f921d4d974712caa2db34109da7434454e9c899e","4dbab4318c3e3be1b91d046dabc701e4278ecced524b465a5ab19b1407f8ce7e","5f36b2d8ef07461e97f808f7f61263a7150357fa6c901b91ad097e8eb49d971b","6207c89d2882799749590d12a91d8c31dd1227fe8c30fdd1e2235cea7ce50bc4","661ae25deb4254f798d5d2f0e79cc307cdb124a9a3d95d45276979a850ddac68","698b61223e82546188a95494c96da922cd6203ced226dc5fd5ca1a05b39bc788","7c780155c16c022e21760169de1504731aadb489db7bff8569413f3c6be0a78b","8343d585f30cb944e9e70444e67d9da0dcc89e0cac2b1d68233b0d93406baca3","874408e493b471ed78324db38f3959444751b8a3bd5eb8f81d5073999640a100","8c6bd5ee91fde3645cc541abf18aeb5663ba313b6ee9baf753f27f1bc38cf441","9f84404c9127de7d275639607015bef09c8162a194af86bf9e86e5326c79e515","b03b9f0cfce9ba118b968cb91a55c808d78b4696d63d2a447e7fe33020d9f2b5","fd875ced30324ebb4b638538b1bb75e38071a51fbf003b1f69785b4ea52c1313"],"recordQualifiers":{},"scopeLabel":"ORPHA:70568","sourceIds":["ORPHA:70568"],"sourceScope":"This column retains the native source entry. It is not a pooled estimate for the umbrella condition."}],"comparison":{"collapseColumnsLabel":"Show default populations","defaultColumnKeys":["population-8bfd114fb2c60b663618"],"expandColumnsLabel":"Show all source populations","intro":"Features recorded for this MONDO node. Related-node evidence is available through separately scoped comparisons.","primaryFeatureIds":["HP:0002027","HP:0001608","HP:0002014","HP:0012378","HP:0001945","HP:0002239","HP:0012115"],"scopeNoteHtml":"<p>Each column retains its native condition identifier, assessed population and annotation references. Counts are not pooled.</p>"},"coverage":{"countRecords":0,"emptyColumnKeys":[],"hpoRelease":"2026-06-23","narrativeSourceChanges":[],"records":16,"sourceGroups":{"orphanet":16}},"features":[{"hpoId":"HP:0002027","label":"Abdominal pain","primary":true},{"hpoId":"HP:0001608","label":"Abnormality of the voice","primary":true},{"hpoId":"HP:0002014","label":"Diarrhea","primary":true},{"hpoId":"HP:0012378","label":"Fatigue","primary":true},{"hpoId":"HP:0001945","label":"Fever","primary":true},{"hpoId":"HP:0002239","label":"Gastrointestinal hemorrhage","primary":true},{"hpoId":"HP:0012115","label":"Hepatitis","primary":true},{"hpoId":"HP:0003073","label":"Hypoalbuminemia","primary":false},{"hpoId":"HP:0002716","label":"Lymphadenopathy","primary":false},{"hpoId":"HP:0033834","label":"Malaise","primary":false},{"hpoId":"HP:0030166","label":"Night sweats","primary":false},{"hpoId":"HP:0033050","label":"Pharyngalgia","primary":false},{"hpoId":"HP:0004396","label":"Poor appetite","primary":false},{"hpoId":"HP:0033608","label":"Pulmonary nodule","primary":false},{"hpoId":"HP:0025267","label":"Snoring","primary":false},{"hpoId":"HP:0001824","label":"Weight loss","primary":false}],"ledeHtml":"Post-transplant lymphoproliferative disease (PTLD) is a complication of transplantation in which there is uncontrolled growth of lymphocytes. It occurs in people whose immune systems have been intentionally suppressed due to having a solid organ transplant or hematopoietic stem cell transplant. The severity of PTLD can range from causing a mild, noncancerous (benign) overgrowth of tissue, to causing a life-threatening, cancerous (malignant) form of lymphoma. Common symptoms are often vague, such as feeling unwell (malaise), fever, weight loss, night sweats, fatigue, and swollen lymph nodes. Additional symptoms depend on the organs or body part(s) affected. The digestive tract, central nervous system, and/or transplanted organ are often involved. PTLD is often caused by Epstein-Barr virus (EBV), which infects lymphocytes called B-cells. Most people get EBV in childhood, but the virus becomes &quot;inactive&quot; because the immune system keeps it under control. In people with PTLD due to EBV, a weakened immune system may allow EBV to reactivate in infected B-cells, leading to their uncontrolled growth. In some cases, EBV from the transplant donor is reactivated in the recipient. PTLD can also occur if a recipient first becomes infected with EBV after the transplant. The reason that PTLD develops in people without EBV is not clear. PTLD is diagnosed by immunophenotyping a biopsy of an involved lymph node or other affected tissue. Additional tests such as blood tests, imaging tests, or bone marrow biopsy may be needed to determine the location(s) and extent of the disease in the body.","mondoId":"MONDO:0019088","node":{"canonicalSlug":"post-transplant-lymphoproliferative-disease","comparisons":[{"documentSha256":"e0ee4eb284acf9986ce74d718591ea2286192da48e3a45555806f26ce24ce34d","key":"legacy-disease-related-to-transplantation","kind":"legacy","label":"disease related to transplantation","memberIds":["MONDO:0013730","MONDO:0019088","MONDO:0020547","MONDO:0700220"],"mondoId":"MONDO:0700220","url":"https://kcjyutqgtpgteszueluf.supabase.co/storage/v1/object/public/community-guides/learn-data/disease-related-to-transplantation.e0ee4eb284acf9986ce74d718591ea2286192da48e3a45555806f26ce24ce34d.json"},{"documentSha256":"1714974dd93aa03098d08a7d8c7ddfd35c1fee1bf41e2d3e916f41a07556d72e","key":"expanded-disease-related-to-transplantation","kind":"expanded","label":"disease related to transplantation","memberIds":["MONDO:0013730","MONDO:0015595","MONDO:0019088","MONDO:0020546","MONDO:0020547","MONDO:0043358","MONDO:0700220","MONDO:0700221","MONDO:0700222"],"mondoId":"MONDO:0700220","url":"https://kcjyutqgtpgteszueluf.supabase.co/storage/v1/object/public/community-guides/learn-data/node-comparison-1714974dd93aa03098d0.1714974dd93aa03098d08a7d8c7ddfd35c1fee1bf41e2d3e916f41a07556d72e.json"}],"contexts":[],"lifecycle":"active","narrative":{"causes":[],"contentForm":"summary","independentCorroborationEstablished":false,"matchMethod":"automatic-identity-and-attribution","name":"Post-transplant lymphoproliferative disease","originalSourceId":"ORPHA:70568","paragraphs":["Post-transplant lymphoproliferative disease (PTLD) is a complication of transplantation in which there is uncontrolled growth of lymphocytes. It occurs in people whose immune systems have been intentionally suppressed due to having a solid organ transplant or hematopoietic stem cell transplant. The severity of PTLD can range from causing a mild, noncancerous (benign) overgrowth of tissue, to causing a life-threatening, cancerous (malignant) form of lymphoma. Common symptoms are often vague, such as feeling unwell (malaise), fever, weight loss, night sweats, fatigue, and swollen lymph nodes. Additional symptoms depend on the organs or body part(s) affected. The digestive tract, central nervous system, and/or transplanted organ are often involved. PTLD is often caused by Epstein-Barr virus (EBV), which infects lymphocytes called B-cells. Most people get EBV in childhood, but the virus becomes \"inactive\" because the immune system keeps it under control. In people with PTLD due to EBV, a weakened immune system may allow EBV to reactivate in infected B-cells, leading to their uncontrolled growth. In some cases, EBV from the transplant donor is reactivated in the recipient. PTLD can also occur if a recipient first becomes infected with EBV after the transplant. The reason that PTLD develops in people without EBV is not clear. PTLD is diagnosed by immunophenotyping a biopsy of an involved lymph node or other affected tissue. Additional tests such as blood tests, imaging tests, or bone marrow biopsy may be needed to determine the location(s) and extent of the disease in the body."],"rawAttribution":"MONDO:0019088","reviewed":null,"scope":"exact","source":"GARD","sourceRelease":"2026-10-25T03:40:38Z","upstream":"GARD:0009553","url":"https://rarediseases.info.nih.gov/diseases/9553"},"ownColumnKeys":["population-8bfd114fb2c60b663618"],"publication":"published","relationships":[{"kind":"parent","label":"disease related to transplantation","mondoId":"MONDO:0700220","slug":"disease-related-to-transplantation"}],"schemaVersion":1,"searchIndex":"/node-search/manifest.json","sourceHolds":{},"summaryHolds":[],"translation":"published"},"records":[{"frequencyKind":"range","key":"05b01c7e8b6468d99cdc25db697dd314200a9f3261cf885e9177e7db96993f92","raw":{"aspect":"P","body_system":"other","disease_id":"ORPHA:70568","disease_name":"Post-transplant lymphoproliferative disease","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0030166","is_excluded":false,"label":"Night sweats","onset_id":null,"reference":"ORPHA:70568","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"1a5f64013ef0d2d7f94fc0a415cdcc9298a793a82d0ad1310456c45e0cb26d16","raw":{"aspect":"P","body_system":"metabolic","disease_id":"ORPHA:70568","disease_name":"Post-transplant lymphoproliferative disease","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0001945","is_excluded":false,"label":"Fever","onset_id":null,"reference":"ORPHA:70568","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"3d11a7187248142e69da02e6e75c495afffe5b20ad15bea2ca60388bdff4fcc8","raw":{"aspect":"P","body_system":"digestive","disease_id":"ORPHA:70568","disease_name":"Post-transplant lymphoproliferative disease","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0002239","is_excluded":false,"label":"Gastrointestinal hemorrhage","onset_id":null,"reference":"ORPHA:70568","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"3dd0c855a1d53c48079c4b67f921d4d974712caa2db34109da7434454e9c899e","raw":{"aspect":"P","body_system":"digestive","disease_id":"ORPHA:70568","disease_name":"Post-transplant lymphoproliferative disease","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0002014","is_excluded":false,"label":"Diarrhea","onset_id":null,"reference":"ORPHA:70568","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"4dbab4318c3e3be1b91d046dabc701e4278ecced524b465a5ab19b1407f8ce7e","raw":{"aspect":"P","body_system":"growth","disease_id":"ORPHA:70568","disease_name":"Post-transplant lymphoproliferative disease","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0001824","is_excluded":false,"label":"Weight loss","onset_id":null,"reference":"ORPHA:70568","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"5f36b2d8ef07461e97f808f7f61263a7150357fa6c901b91ad097e8eb49d971b","raw":{"aspect":"P","body_system":"metabolic","disease_id":"ORPHA:70568","disease_name":"Post-transplant lymphoproliferative disease","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0003073","is_excluded":false,"label":"Hypoalbuminemia","onset_id":null,"reference":"ORPHA:70568","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"6207c89d2882799749590d12a91d8c31dd1227fe8c30fdd1e2235cea7ce50bc4","raw":{"aspect":"P","body_system":"head_and_neck","disease_id":"ORPHA:70568","disease_name":"Post-transplant lymphoproliferative disease","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0001608","is_excluded":false,"label":"Abnormality of the voice","onset_id":null,"reference":"ORPHA:70568","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"661ae25deb4254f798d5d2f0e79cc307cdb124a9a3d95d45276979a850ddac68","raw":{"aspect":"P","body_system":"digestive","disease_id":"ORPHA:70568","disease_name":"Post-transplant lymphoproliferative disease","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0012115","is_excluded":false,"label":"Hepatitis","onset_id":null,"reference":"ORPHA:70568","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"698b61223e82546188a95494c96da922cd6203ced226dc5fd5ca1a05b39bc788","raw":{"aspect":"P","body_system":"other","disease_id":"ORPHA:70568","disease_name":"Post-transplant lymphoproliferative disease","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0033834","is_excluded":false,"label":"Malaise","onset_id":null,"reference":"ORPHA:70568","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"7c780155c16c022e21760169de1504731aadb489db7bff8569413f3c6be0a78b","raw":{"aspect":"P","body_system":"other","disease_id":"ORPHA:70568","disease_name":"Post-transplant lymphoproliferative disease","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0033050","is_excluded":false,"label":"Pharyngalgia","onset_id":null,"reference":"ORPHA:70568","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"8343d585f30cb944e9e70444e67d9da0dcc89e0cac2b1d68233b0d93406baca3","raw":{"aspect":"P","body_system":"digestive","disease_id":"ORPHA:70568","disease_name":"Post-transplant lymphoproliferative disease","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0004396","is_excluded":false,"label":"Poor appetite","onset_id":null,"reference":"ORPHA:70568","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"874408e493b471ed78324db38f3959444751b8a3bd5eb8f81d5073999640a100","raw":{"aspect":"P","body_system":"respiratory","disease_id":"ORPHA:70568","disease_name":"Post-transplant lymphoproliferative disease","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0033608","is_excluded":false,"label":"Pulmonary nodule","onset_id":null,"reference":"ORPHA:70568","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"8c6bd5ee91fde3645cc541abf18aeb5663ba313b6ee9baf753f27f1bc38cf441","raw":{"aspect":"P","body_system":"other","disease_id":"ORPHA:70568","disease_name":"Post-transplant lymphoproliferative disease","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0012378","is_excluded":false,"label":"Fatigue","onset_id":null,"reference":"ORPHA:70568","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"9f84404c9127de7d275639607015bef09c8162a194af86bf9e86e5326c79e515","raw":{"aspect":"P","body_system":"other","disease_id":"ORPHA:70568","disease_name":"Post-transplant lymphoproliferative disease","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0002027","is_excluded":false,"label":"Abdominal pain","onset_id":null,"reference":"ORPHA:70568","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"b03b9f0cfce9ba118b968cb91a55c808d78b4696d63d2a447e7fe33020d9f2b5","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:70568","disease_name":"Post-transplant lymphoproliferative disease","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0025267","is_excluded":false,"label":"Snoring","onset_id":null,"reference":"ORPHA:70568","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"fd875ced30324ebb4b638538b1bb75e38071a51fbf003b1f69785b4ea52c1313","raw":{"aspect":"P","body_system":"immune","disease_id":"ORPHA:70568","disease_name":"Post-transplant lymphoproliferative disease","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0002716","is_excluded":false,"label":"Lymphadenopathy","onset_id":null,"reference":"ORPHA:70568","source_release":"2026-06-23"},"sourceGroups":["orphanet"]}],"referenceLabels":{},"references":{"causeHtml":"<p class=\"section-source\">Source: <a href=\"https://rarediseases.info.nih.gov/diseases/9553\" rel=\"noreferrer\">GARD</a></p><p class=\"section-source\">Source: <a href=\"https://monarchinitiative.org/MONDO:0019088\" rel=\"noreferrer\">MONDO</a></p><details class=\"deep-dive\"><summary>Narrative source and scope</summary><dl><dt>Content</dt><dd>summary</dd><dt>Scope</dt><dd>exact</dd><dt>Match method</dt><dd>automatic-identity-and-attribution</dd><dt>Upstream attribution</dt><dd>GARD:0009553</dd></dl></details>","identityNote":"MONDO identifies this node. Native source populations, annotation references and qualified comparison views retain their original scopes.","importantHtml":""},"sections":[{"bodyHtml":"<p>Post-transplant lymphoproliferative disease (PTLD) is a complication of transplantation in which there is uncontrolled growth of lymphocytes. It occurs in people whose immune systems have been intentionally suppressed due to having a solid organ transplant or hematopoietic stem cell transplant. The severity of PTLD can range from causing a mild, noncancerous (benign) overgrowth of tissue, to causing a life-threatening, cancerous (malignant) form of lymphoma. Common symptoms are often vague, such as feeling unwell (malaise), fever, weight loss, night sweats, fatigue, and swollen lymph nodes. Additional symptoms depend on the organs or body part(s) affected. The digestive tract, central nervous system, and/or transplanted organ are often involved. PTLD is often caused by Epstein-Barr virus (EBV), which infects lymphocytes called B-cells. Most people get EBV in childhood, but the virus becomes &quot;inactive&quot; because the immune system keeps it under control. In people with PTLD due to EBV, a weakened immune system may allow EBV to reactivate in infected B-cells, leading to their uncontrolled growth. In some cases, EBV from the transplant donor is reactivated in the recipient. PTLD can also occur if a recipient first becomes infected with EBV after the transplant. The reason that PTLD develops in people without EBV is not clear. PTLD is diagnosed by immunophenotyping a biopsy of an involved lymph node or other affected tissue. Additional tests such as blood tests, imaging tests, or bone marrow biopsy may be needed to determine the location(s) and extent of the disease in the body.</p><p class=\"section-source\">Source: <a href=\"https://rarediseases.info.nih.gov/diseases/9553\" rel=\"noreferrer\">GARD</a></p>","key":"overview","title":"Overview"}],"sharedSources":[],"slug":"post-transplant-lymphoproliferative-disease","sourceDocuments":[{"name":"GARD: Post-transplant lymphoproliferative disease","reviewed":null,"source_release":"2026-10-25T03:40:38Z","url":"https://rarediseases.info.nih.gov/diseases/9553"},{"name":"MONDO: post-transplant lymphoproliferative disease","reviewed":null,"source_release":"releases/2026-10-06","url":"https://monarchinitiative.org/MONDO:0019088"}],"sourceNote":"","synonyms":["post-transplant lymphoproliferative disorder","PTLD"],"takeawayHtml":"","title":"post-transplant lymphoproliferative disease"},"schemaVersion":1}
